More than three-quarters of selected patients with hypertrophic cardiomyopathy who underwent epicardial and endocardial catheter ablation were free of implantable cardioverter defibrillator shocks ...

Patients with a severe form of ventricular arrhythmia who may be referred for catheter ablation are often first tested for coronary artery disease (CAD) or ischemia. But such testing seldom makes a ...

BERLIN, Germany—Treatment of monomorphic ventricular tachycardia (VT) with a novel ultralow-temperature cryoablation catheter (vCLAS; Adagio Medical) appears to be safe and effective in patients with ...

Study Results are Intended to Support PMA Approval of Adagio’s vCLAS TM Cryoablation System Designed to Address the Large Population of Patients with Ventricular Arrhythmias LAGUNA HILLS, Calif., ...

Dr. Verma said, "ULTC ablation of monomorphic VT was effective and relatively safe in patients with ischemic and non-ischemic cardiomyopathies. The success rates for this novel procedure were at least ...

Patients with structural heart disease and monomorphic ventricular tachycardia (VT), irrespective of its etiology, can benefit when early first-line catheter ablation is added before implanting an ...

This page lists all known medications that could potentially lead to 'Monomorphic ventricular tachycardia' as a side effect. It's important to note that mild side effects are quite common with ...

A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a ...

Thus, the interlacing of viable and nonviable myocardium is capable of satisfying the three conditions required for initiation and maintenance of a reentrant rhythm: (1) at least two functionally (or ...

A 52-year-old man with hypertension and hyperlipidemia experiences chest pain and summons medical help. Thirty minutes later, in the presence of paramedics, he collapses with ventricular fibrillation ...